Guardian Pharmacy Services, Inc.
GRDN
$23.24
-$0.87-3.61%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.42% | 16.86% | 14.66% | 14.59% | 15.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.42% | 16.86% | 14.66% | 14.59% | 15.10% |
| Cost of Revenue | 17.44% | 17.45% | 15.32% | 15.69% | 15.88% |
| Gross Profit | 17.31% | 14.49% | 12.09% | 10.35% | 12.08% |
| SG&A Expenses | 110.44% | 69.25% | 22.45% | -8.35% | 7.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.08% | 26.14% | 16.37% | 11.52% | 14.57% |
| Operating Income | -190.81% | -198.12% | -9.84% | 90.22% | 23.87% |
| Income Before Tax | -276.24% | -276.71% | -49.95% | 26.56% | -24.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -288.32% | -277.17% | -49.95% | 26.56% | -24.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.63% | -26.16% | -13.79% | 4.07% | 2.96% |
| Net Income | -465.19% | -469.83% | -69.64% | 50.86% | -32.52% |
| EBIT | -190.81% | -198.12% | -9.84% | 90.22% | 23.87% |
| EBITDA | -146.84% | -136.07% | -5.74% | 64.92% | 20.54% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.26% | -1.40% | 3.99% | 0.48% | 0.85% |